LETTER OF INTENTLetter of Intent • March 17th, 2003 • Antex Biologics Inc • Biological products, (no disgnostic substances)
LETTER OF INTENT, dated as of February 28, 2003 (this “Letter of Intent ”), by and between ANTEX BIOLOGICS INC., a Delaware corporation with executive offices at 300 Professional Drive, Gaithersburg, Maryland 20879 (“Antex”) and BioPort Corporation, a Michigan corporation with executive offices at 3500 N. Martin Luther King Jr. Blvd., Lansing, MI 48906-9910 (“BioPort”).
DISCRETIONARY LOAN, SECURITY AND PLEDGE AGREEMENTLoan, Security and Pledge Agreement • March 17th, 2003 • Antex Biologics Inc • Biological products, (no disgnostic substances) • Delaware
THIS DISCRETIONARY LOAN, SECURITY AND PLEDGE AGREEMENT (“Agreement”) is made as of March 17, 2003, by and between ANTEX BIOLOGICS INC., a Delaware corporation (“Antex”) and ANTEX PHARMA INC., a Delaware corporation and wholly-owned subsidiary of Antex (the “Subsidiary”), and BIOPORT CORPORATION, a Michigan corporation (“Lender”). Antex and Subsidiary are sometimes individually referred to in this Agreement as the “Borrower” and collectively as the “Borrowers”.
